ESSA Pharma Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ESSA Pharma Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2019 to Q4 2023.
  • ESSA Pharma Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $197K, a 1156% increase year-over-year.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$68.2K, a 127% decline from 2022.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $253K.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $142M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $197K +$181K +1156% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q4 2022 $15.7K -$83.7K -84.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q4 2021 $99.3K -$51.6K -34.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q4 2020 $151K +$4.19M Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q4 2019 -$4.04M Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.